Please assess the completion status of the following clinical trial:

Trial Title: Sodium Supplementation and Growth in Very Low Birth Weight Infants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* infants born at less than 32 weeks postmenstrual age~Exclusion Criteria:~* infants with major malformations deemed incompatible with life disease states characterized by edema renal failure, defined as an increase in serum creatinine by 0.5 mg/dl/day or urine output less than 0.5 ml/kg/hour

- Gender: ALL
- Minimum Age: 7 Days
- Maximum Age: 8 Days
- Healthy Volunteers: f

Study Arms:
- Sodium chloride (Type: ACTIVE_COMPARATOR): Sodium chloride 1 meq/kg (0.4 ml/kg of 2.5meq/ml formulation for injection)q6hrs on days of life 7-35. Intervention was given enterally if feedings were at least 100 ml/kg/day; otherwise medication was diluted in equal amounts of dextrose 5% water and administered intravenously.
- sterile water (Type: PLACEBO_COMPARATOR): Sterile water, 0.4 ml/kg q6hrs on days of life 7-35. Placebo is given enterally when infant is tolerating at least 100 ml/kg/day; otherwise the product is diluted in equal amounts of dextrose 5% water and administered intravenously.

Based on this trial design, predict the completion outcome and termination type (if applicable).